Market News

Barry Investment Advisors Holding in Teva Pharmaceutical Inds LTD (TEVA) Has Decreased as Share Value Declined; As Pandora Media (P) Stock Declined, Corvex Management LP Lowered Position

Keith Meister decreased its stake in Pandora Media Inc (P) by 45.03% based on its latest 2017Q3 regulatory filing with the SEC. Corvex Management Lp sold 9.35 million shares as the company’s stock declined 31.96% while stock markets rallied. The hedge fund run by Keith Meister held 11.41M shares of the consumer services company at the end of 2017Q3, valued at $87.88M, down from 20.76 million at the end of the previous reported quarter. Corvex Management Lp who had been investing in Pandora Media Inc for a number of months, seems to be less bullish one the $1.28B market cap company. The stock increased 2.18% or $0.11 during the last trading session, reaching $5.16. About 14.58 million shares traded or 56.03% up from the average. Pandora Media, Inc. (NYSE:P) has declined 12.50% since February 19, 2017 and is downtrending. It has underperformed by 29.20% the S&P500.

Barry Investment Advisors Llc decreased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 44.38% based on its latest 2017Q3 regulatory filing with the SEC. Barry Investment Advisors Llc sold 56,063 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 70,274 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.24 million, down from 126,337 at the end of the previous reported quarter. Barry Investment Advisors Llc who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be less bullish one the $21.25 billion market cap company. The stock increased 0.43% or $0.09 during the last trading session, reaching $20.9. About 14.77M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 19, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 146 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Friday, August 4 by Cowen & Co. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Buy” rating given on Wednesday, November 16 by Deutsche Bank. The firm has “Neutral” rating given on Friday, February 10 by Mizuho. Barclays Capital maintained it with “Equal-Weight” rating and $21 target in Wednesday, October 4 report. On Monday, August 10 the stock rating was maintained by Goldman Sachs with “Buy”. Argus Research maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Tuesday, July 28. Argus Research has “Buy” rating and $82 target. The rating was maintained by Maxim Group with “Hold” on Thursday, July 13. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Neutral” rating given on Tuesday, September 29 by Nomura. On Wednesday, September 6 the stock rating was maintained by JMP Securities with “Underperform”. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Sell” rating by Credit Suisse on Tuesday, September 5.

Corvex Management Lp, which manages about $8.18B and $2.66B US Long portfolio, upped its stake in Facebook Inc (NASDAQ:FB) by 12,000 shares to 829,000 shares, valued at $141.65M in 2017Q3, according to the filing. It also increased its holding in Envision Healthcare Corp by 4.66 million shares in the quarter, for a total of 5.61M shares, and has risen its stake in Centurylink Inc (NYSE:CTL).

Since August 31, 2017, it had 0 insider buys, and 1 sale for $250,075 activity.

Leave a Reply

Your email address will not be published. Required fields are marked *